The pleural mesothelium in development and disease

Frontiers in Physiology

Volumn 5 JUL, Issue , 2014, Pages

  Batra, Hitesh ^a   Antony, Veena B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Epithelial mesenchymal transition (EMT); Idiopathic pulmonary fibrosis (IPF); Pleural mesothelial cells; Pleural mesothelium; Wilms tumor 1 (WT1)

Indexed keywords

BETA CATENIN; BLEOMYCIN; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; MESOTHELIN; NANOPARTICLE; POLYGLACTIN; TRANSCRIPTION FACTOR SOX2; WNT PROTEIN; WT1 PROTEIN;

ARTICLE; CELL FUNCTION; DRUG DELIVERY SYSTEM; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; GENE; GENE THERAPY; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; MESODERM; MESOTHELIUM CELL; MYOFIBROBLAST; NONHUMAN; PLEURA DISEASE; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; WT1 GENE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; MESOTHELIUM; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PLEURAL MESOTHELIUM; PROTEIN DETERMINATION; PROTEIN FUNCTION; TARGET CELL;

EID: 84904352123     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00284     Document Type: Article

References (69)

1. Jantz, M.A. and V.B. Antony, Pleural fibrosis. Clin Chest Med, 2006. 27(2): p. 181-91.
2. Haber, D.A., et al., An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 1990. 61(7): p. 1257-69.
3. Park, S., et al., The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet, 1993. 4(4): p. 415-20.
4. Jomgeow, T., et al., Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci, 2006. 97(4): p. 259-70.
5. Ito, K., et al., Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene, 2006. 25(30): p. 4217-29.
6. Colvin, J.S., et al., Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development, 2001. 128(11): p. 2095-106.
7. Dixit, R., X. Ai, and A. Fine, Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry. Development, 2013. 140(21): p. 4398-406.
8. Herriges, M. and E.E. Morrisey, Lung development: orchestrating the generation and regeneration of a complex organ. Development, 2014. 141(3): p. 502-13.
9. Que, J., et al., Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc Natl Acad Sci U S A, 2008. 105(43): p. 16626-30.
10. Weaver, M., N.R. Dunn, and B.L. Hogan, Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development, 2000. 127(12): p. 2695-704.
11. Bellusci, S., et al., Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development, 1997. 124(1): p. 53-63.
12. Sekine, K., et al., Fgf10 is essential for limb and lung formation. Nat Genet, 1999. 21(1): p. 138-41.
13. Goss, A.M., et al., Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell, 2009. 17(2): p. 290-8.
14. Domyan, E.T., et al., Signaling through BMP receptors promotes respiratory identity in the foregut via repression of Sox2. Development, 2011. 138(5): p. 971-81.
15. Ohuchi, H., et al., FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun, 2000. 277(3): p. 643-9.
16. Pepicelli, C.V., P.M. Lewis, and A.P. McMahon, Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol, 1998. 8(19): p. 1083-6.
17. Call, K.M., et al., Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 1990. 60(3): p. 509-20.
18. Zhou, B., et al., Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol, 2010. 338(2): p. 251-61.
19. Zhou, B., et al., Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest, 2011. 121(5): p. 1894-904.
20. Cai, C.L., et al., A myocardial lineage derives from Tbx18 epicardial cells. Nature, 2008. 454(7200): p. 104-8.
21. Dettman, R.W., et al., Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol, 1998. 193(2): p. 169-81.
22. Mikawa, T. and R.G. Gourdie, Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol, 1996. 174(2): p. 221-32.
23. Wilm, B., et al., The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development, 2005. 132(23): p. 5317-28.
24. Kawaguchi, M., D.M. Bader, and B. Wilm, Serosal mesothelium retains vasculogenic potential. Dev Dyn, 2007. 236(11): p. 2973-9.
25. Burwell, E.A., et al., Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene, 2007. 26(23): p. 3423-30.
26. Zhang, T.F., et al., Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. Anticancer Res, 2003. 23(5A): p. 3575-84.
27. Loeb, D.M., et al., Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res, 2001. 61(3): p. 921-5.
28. Oji, Y., et al., Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer, 2002. 100(3): p. 297-303.
29. Ueda, T., et al., Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci, 2003. 94(3): p. 271-6.
30. Licciulli, S. and J.L. Kissil, WT1: a weak spot in KRAS-induced transformation. J Clin Invest, 2010. 120(11): p. 3804-7.
31. Amin, K.M., et al., Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed ed in malignant mesothelioma. Am J Pathol, 1995. 146(2): p. 344-56.
32. Bax, N.A., et al., In vitro epithelial-to-mesenchymal transformation in human adult epicardial cells is regulated by TGFbeta-signaling and WT1. Basic Res Cardiol, 2011. 106(5): p. 829-47.
33. Bax, N.A., et al., Epithelial-to-mesenchymal transformation alters electrical conductivity of human epicardial cells. J Cell Mol Med, 2011.
34. Hecker, L., et al., NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med, 2009. 15(9): p. 1077-81.
35. Nasreen, N., et al., Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol, 2009. 297(1): p. L115-24.
36. Zolak, J.S., et al., Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury. Am J Pathol, 2013. 182(4): p. 1239-47.
37. Mutsaers, S.E., Mesothelial cells: their structure, function and role in serosal repair. Respirology, 2002. 7(3): p. 171-91.
38. Munoz-Chapuli, R., et al., Differentiation of hemangioblasts from embryonic mesothelial cells? A model on the origin of the vertebrate cardiovascular system. Differentiation, 1999. 64(3): p. 133-41.
39. Perez-Pomares, J.M., et al., Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. Int J Dev Biol, 2002. 46(8): p. 1005-13.
40. Perez-Pomares, J.M., et al., Contribution of mesothelium-derived cells to liver sinusoids in avian embryos. Dev Dyn, 2004. 229(3): p. 465-74.
41. Herrick, S.E. and S.E. Mutsaers, Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol, 2004. 36(4): p. 621-42.
42. Rinkevich, Y., et al., Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat Cell Biol, 2012. 14(12): p. 1251-60.
43. Lansley, S.M., et al., Mesothelial cell differentiation into osteoblast-and adipocyte-like cells. J Cell Mol Med, 2011. 15(10): p. 2095-105.
44. Donna, A. and P.G. Betta, Mesodermomas: a new embryological approach to primary tumours of coelomic surfaces. Histopathology, 1981. 5(1): p. 31-44.
45. Wada, A.M., et al., Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res, 2003. 92(5): p. 525-31.
46. Yang, A.H., J.Y. Chen, and J.K. Lin, Myofibroblastic conversion of mesothelial cells. Kidney Int, 2003. 63(4): p. 1530-9.
47. Decologne, N., et al., TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol, 2007. 179(9): p. 6043-51.
48. Margetts, P.J., et al., Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol, 2005. 16(2): p. 425-36.
49. Schramm, A., et al., Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg, 2010. 37(3): p. 566-72.
50. Komiya, E., et al., CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells. Biochem Biophys Res Commun, 2014. 447(4): p. 609-15.
51. Havre, P.A., et al., The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci, 2008. 13: p. 1634-45.
52. King, T.E., Jr., A. Pardo, and M. Selman, Idiopathic pulmonary fibrosis. Lancet, 2011. 378(9807): p. 1949-61.
53. King, T.E., Jr., et al., Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med, 2001. 164(6): p. 1025-32.
54. King, T.E., Jr., et al., Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med, 2001. 164(7): p. 1171-81.
55. Cool, C.D., et al., Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med, 2006. 174(6): p. 654-8.
56. Phan, S.H., Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc, 2008. 5(3): p. 334-7.
57. Raghu, G., et al., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011. 183(6): p. 788-824.
58. King, T.E., Jr., A. Pardo, and M. Selman, Idiopathic pulmonary fibrosis. Lancet, 2011.
59. Mohammed, K.A., N. Nasreen, and V.B. Antony, Bacterial induction of early response genes and activation of proapoptotic factors in pleural mesothelial cells. Lung, 2007. 185(6): p. 355-65.
60. Antony, V.B., Immunological mechanisms in pleural disease. Eur Respir J, 2003. 21(3): p. 539-44.
61. Mubarak, K.K., et al., Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J, 2011.
62. Hagiwara, S.I., Y. Ishii, and S. Kitamura, Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med, 2000. 162(1): p. 225-31.
63. Matsuoka, H., et al., A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2002. 283(1): p. L103-12.
64. Simler, N.R., et al., The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J, 2002. 19(6): p. 1124-7.
65. Murakami, S., et al., Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol, 2006. 290(1): p. L59-65.
66. Mubarak, K.K., et al., Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J, 2012. 39(1): p. 133-40.
67. Watanabe, M., J.L. Boyer, and R.G. Crystal, AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther, 2010. 17(8): p. 1042-51.
68. Perez-Soler, R., et al., Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clin Cancer Res, 1997. 3(3): p. 373-9.
69. Liu, J., et al., Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer, 2006. 51(3): p. 377-86.